Cravit 1.5% Ophthalmic Solution Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Adverse Reactions

Adverse reactions (treatment-related adverse events) were reported in 7 of 238 patients (2.9%) and in 1 of 8 healthy subjects (12.5%) in clinical trials in Japan. The adverse reactions were eye irritation in 3 patients (1.3%), dysgeusia in 2 patients (0.8%) and 1 healthy subject (12.5%), eye itching in 1 patient (0.4%), and urticaria in 1 patient (0.4%).
Clinically significant adverse reactions: Shock, anaphylactoid reaction (incidences unknown): Since shock and anaphylactoid reaction may occur, patients should be carefully observed. If any symptoms such as erythema, rash, dyspnoea, decreased blood pressure, and eyelid oedema, etc. are observed, administration should be discontinued and appropriate measures should be taken.
Other adverse reactions: If any adverse reactions are observed, appropriate measures such as discontinuing administration should be taken. (See table as follows.)

Click on icon to see table/diagram/image

View ADR Monitoring Form

Cravit 1.5% Ophthalmic Solution Adverse Reactions

levofloxacin

Manufacturer:

Santen

Distributor:

Zuellig Pharma